Alligator Bioscience AB Cash Flow Conversion Efficiency

Latest as of June 2026: -4.204x

Alligator Bioscience AB cash flow conversion efficiency. Based on the latest financial reports, Alligator Bioscience AB (ATORX) has a cash flow conversion efficiency ratio of -4.204x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-13.99 Million ≈ $-1.51 Million USD) by net assets (Skr3.33 Million ≈ $358.04K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Alligator Bioscience AB (2011–2025)

Cash flow conversion efficiency of Alligator Bioscience AB from 2011 to 2025. This chart illustrates how Alligator Bioscience AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Alligator Bioscience AB (ATORX) share price today for real-time trading data and today's change.

Alligator Bioscience AB Cash Flow Conversion Ratio Explained

Alligator Bioscience AB cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Alligator Bioscience AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Alligator Bioscience AB ranked by their cash flow conversion efficiency. Also see ATORX company net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Metavisio (Thomson Computing) PA:ALTHO	-0.002x
Rover Metals Corp V:ROVR	-0.003x
Stelmine Canada Ltd V:STH	0.019x
Aethlon Medical Inc NASDAQ:AEMD	-364.766x
Optiva Inc TO:OPT	0.071x
Arctic Blue Beverages AB ST:ARCTIC	0.146x
Lithium One Metals Inc V:LONE	-0.004x
Ten Lifestyle Group PLC LSE:TENG	0.186x

Annual Cash Flow Conversion Efficiency for Alligator Bioscience AB (2011–2025)

The table below shows the annual cash flow conversion efficiency of Alligator Bioscience AB from 2011 to 2025. Review ATORX cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr6.86 Million ≈ $738.14K	Skr-155.99 Million ≈ $-16.79 Million	-22.742x	-1498.03%
2024-12-31	Skr-130.59 Million ≈ $-14.05 Million	Skr-212.43 Million ≈ $-22.86 Million	1.627x	+110.19%
2023-12-31	Skr11.86 Million ≈ $1.28 Million	Skr-189.28 Million ≈ $-20.37 Million	-15.967x	-723.75%
2022-12-31	Skr89.05 Million ≈ $9.58 Million	Skr-172.61 Million ≈ $-18.58 Million	-1.938x	-330.70%
2021-12-31	Skr282.27 Million ≈ $30.38 Million	Skr-127.03 Million ≈ $-13.67 Million	-0.450x	+63.31%
2020-12-31	Skr115.24 Million ≈ $12.40 Million	Skr-141.35 Million ≈ $-15.21 Million	-1.227x	-77.16%
2019-12-31	Skr258.50 Million ≈ $27.82 Million	Skr-178.96 Million ≈ $-19.26 Million	-0.692x	-211.41%
2018-12-31	Skr468.31 Million ≈ $50.40 Million	Skr-104.11 Million ≈ $-11.20 Million	-0.222x	-37.90%
2017-12-31	Skr617.96 Million ≈ $66.50 Million	Skr-99.63 Million ≈ $-10.72 Million	-0.161x	-189.86%
2016-12-31	Skr676.18 Million ≈ $72.77 Million	Skr-37.61 Million ≈ $-4.05 Million	-0.056x	-110.78%
2015-12-31	Skr396.97 Million ≈ $42.72 Million	Skr204.89 Million ≈ $22.05 Million	0.516x	+156.37%
2014-12-31	Skr68.52 Million ≈ $7.37 Million	Skr-62.74 Million ≈ $-6.75 Million	-0.916x	+43.36%
2011-12-31	Skr21.51 Million ≈ $2.31 Million	Skr-34.77 Million ≈ $-3.74 Million	-1.617x	--

About Alligator Bioscience AB

ST:ATORX Sweden Biotechnology

Market Cap

$1.10 Million

Skr10.26 Million SEK

Market Cap Rank

#30604 Global

#700 in Sweden

Share Price

Skr0.01

Change (1 day)

-11.20%

52-Week Range

Skr0.01 - Skr1.92

All Time High

Skr55.78